Background Identifying new drug targets for inflammatory bowel disease (IBD) is urgently
needed. The proteome is a major source of therapeutic targets. We conducted a proteome …

IBD (inflammatory bowel disease) is a chronic inflammatory disease of the gastrointestinal
tract with increasing incidence worldwide. Multiple factors, such as genetic background …

Simple Summary Patients with inflammatory bowel disease (IBD) are at an increased risk of
developing colorectal cancer (CRC), mainly because of chronic intestinal inflammation …

This guideline is the second European Crohn's and Colitis Organisation [ECCO] evidence-
based consensus on inflammatory bowel disease [IBD] and malignancy, and is an update …

Background Evidence on real‐world outcomes of ustekinumab for ulcerative colitis (UC)
patients is needed. Aims To summarise evidence on the real‐world outcomes of …

Ulcerative colitis (UC) is a common progressive inflammatory disease whose incidence has
increased rapidly in recent years, and can develop into colorectal cancer in severe cases …

Abstract Inflammatory Bowel Disease (IBD) are autoimmune diseases characterized by
chronic intestinal inflammation. Considered a western disease, IBD incidence in newly …

Simple Summary Crohn's disease (CD) and ulcerative colitis (UC) are chronic inflammatory
bowel diseases that affect the gut and extraintestinal organs. Preliminary evidence has …

Objective This study aimed to evaluate ustekinumab efficacy, effectiveness, and safety as a
treatment for ulcerative colitis in adult patients. Methods A systematic review of the efficacy …

The recent approval of new medications with novel mechanisms of action and emergence of
updated safety information for existing therapies has changed the treatment landscape of …